63149-33-7 | 8-Hydroxyjulolidine-9-aldehyde

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$30.00	$21.00
5g	98%	in stock	$132.00	$92.00
10g	98%	in stock	$259.00	$181.00
25g	98%	in stock	$463.00	$324.00

Description

• Catalog Number: AB70238
• Chemical Name: 8-Hydroxyjulolidine-9-aldehyde
• CAS Number: 63149-33-7
• Molecular Formula: C13H15NO2
• Molecular Weight: 217.2637
• MDL Number: MFCD00192477
• SMILES: O=Cc1cc2CCCN3c2c(c1O)CCC3

Computed Properties

• Complexity: 281
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 16
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 1
• XLogP3: 2.5

Upstream Synthesis Route

The 8-Hydroxy-1,2,3,5,6,7-hexahydropyrido[3,2,1-ij]quinoline-9-carbaldehyde is a versatile compound widely used in chemical synthesis. Its unique molecular structure allows it to serve as a key building block in the creation of various organic molecules.One of the primary applications of 8-Hydroxy-1,2,3,5,6,7-hexahydropyrido[3,2,1-ij]quinoline-9-carbaldehyde in chemical synthesis is its role as a precursor in the synthesis of heterocyclic compounds. By utilizing the aldehyde functional group present in this compound, chemists can introduce diverse chemical substitutions and modifications to generate a wide range of heterocyclic structures.Additionally, the presence of the hydroxy group in 8-Hydroxy-1,2,3,5,6,7-hexahydropyrido[3,2,1-ij]quinoline-9-carbaldehyde enables it to participate in various organic reactions, such as condensation reactions and oxidative transformations. This versatility makes it a valuable component in the development of novel organic compounds with potential applications in pharmaceuticals, agrochemicals, and materials science.Overall, the 8-Hydroxy-1,2,3,5,6,7-hexahydropyrido[3,2,1-ij]quinoline-9-carbaldehyde is a crucial intermediate in chemical synthesis, facilitating the creation of diverse and complex organic molecules through its involvement in key synthetic pathways.

Literature

• Synthesis of novel tricyclic chromenone-based inhibitors of IRE-1 RNase activity.

  Journal of medicinal chemistry 20140522

• Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight.

  Molecular pharmacology 20090801

• Synthesis and anti-angiogenesis activity of coumarin derivatives.

  Bioorganic & medicinal chemistry letters 20060901